| 臺大學術典藏 |
2022-06-27T07:06:41Z |
Sialyl Lewis antigens: Association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer
|
CHONG-JEN YU; Shih J.-Y.; Lee Y.-C.; Shun C.-T.; Yuan A.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:39Z |
Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients
|
Yuan A.; CHONG-JEN YU; Shun C.-T.; Luh K.-T.; Kuo S.-H.; Lee Y.-C.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:30Z |
Role of the renin-angiotensin system in ventilator-induced lung injury: An in vivo study in a rat model
|
Jerng J.-S.; Hsu Y.-C.; Wu H.-D.; Pan H.-Z.; Wang H.-C.; Shun C.-T.; CHONG-JEN YU; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:20Z |
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy
|
Yang C.-H.; CHONG-JEN YU; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-10T06:11:15Z |
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy
|
Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; ZHONG-ZHE LIN; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C. |
| 臺大學術典藏 |
2022-05-13T08:05:26Z |
Secular changes in the clinical manifestation and pathologic pattern of early gastric cancer in Taiwan.
|
Lin J.T.; Wu M.S.; JANN-TAY WANG; Chen K.M.; Wei T.C.; Shun C.T.; Chen C.J.; Wang H.P.; Chan T.M.; Wang T.H. |
| 臺大學術典藏 |
2022-05-05T08:48:56Z |
Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: Early outcome and technical impact on toxicity
|
CHIA-CHUN WANG; Liang J.-T.; Tsai C.-L.; Chen Y.-H.; Lin Y.-L.; Shun C.-T.; Cheng J.C.-H. |
| 臺大學術典藏 |
2022-04-21T06:51:12Z |
Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men
|
Chiu H.-M.; Lin J.-T.; Chen, Tony Hsiu Hsi; Lee Y.-C.; Chiu Y.-H.; Liang J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-04-21T06:50:49Z |
The benefit of mass eradication of helicobacter pylori infection: A community-based study of gastric cancer prevention
|
Lee Y.-C.; Chen, Tony Hsiu Hsi; Chiu H.-M.; Shun C.-T.; Chiang H.; Liu T.-Y.; Wu M-S.; Lin J.-T. |
| 臺大學術典藏 |
2022-04-21T06:50:18Z |
Serum pepsinogen as a predictor for gastric cancer death A 16-year community-based cohort study
|
Chiang T.-H.; Chiu S.Y.-H.; Chen S.L.-S.; Yen A.M.-F.; Fann J.C.-Y.; Liu C.-Y.; Chou C.-K.; Chiu H.-M.; Shun C.-T.; Wu M.-S.; Lin J.-T.; Lee Y.-C.; Chen, Tony Hsiu Hsi; Lin M.-W. |
| 臺大學術典藏 |
2022-04-21T06:50:09Z |
Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: A long-term cohort study on Matsu Islands
|
Chiang T.-H.; Chang W.-J.; Chen S.L.-S.; Yen A.M.-F.; Fann J.C.-Y.; Chiu S.Y.-H.; Chen Y.-R.; Chuang S.-L.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; Chan C.-C.; Graham D.Y.; Chen, Tony Hsiu Hsi; Lee Y.-C. |
| 臺大學術典藏 |
2022-04-21T06:50:08Z |
Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands
|
Chiang T.-H.; Maeda M.; Yamada H.; Chan C.-C.; Chen S.L.-S.; Chiu S.Y.-H.; Chen Y.-N.; Chou Y.-H.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; Chen, Tony Hsiu Hsi; Ushijima T.; Graham D.Y.; Lee Y.-C. |
| 臺大學術典藏 |
2022-03-24T03:27:03Z |
Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: A long-term cohort study on Matsu Islands
|
Chiang T.-H.; Chang W.-J.; Chen S.L.-S.; Yen A.M.-F.; Fann J.C.-Y.; Chiu S.Y.-H.; Chen Y.-R.; Chuang S.-L.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; CHANG-CHUAN CHAN; Graham D.Y.; Chen H.-H.; Lee Y.-C. |
| 臺大學術典藏 |
2022-03-24T03:27:02Z |
Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands
|
Chiang T.-H.; Maeda M.; Yamada H.; CHANG-CHUAN CHAN; Chen S.L.-S.; Chiu S.Y.-H.; Chen Y.-N.; Chou Y.-H.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; Chen H.-H.; Ushijima T.; Graham D.Y.; Lee Y.-C. |
| 臺大學術典藏 |
2022-03-10T07:58:38Z |
Case report: Mismatch repair proficiency and microsatellite stability in gastric cancer may not predict programmed death-1 blockade resistance
|
Chen K.-H.; Yuan C.-T.; LI-HUI TSENG; Shun C.-T.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-10T05:59:39Z |
Prostaglandin reductase 2 modulates ros-mediated cell death and tumor transformation of gastric cancer cells and is associated with higher mortality in gastric cancer patients
|
Yun-Chia Chang E.; Tsai S.-H.; Shun C.-T.; Hee S.-W.; YI-CHENG CHANG; Tsai Y.-C.; Tsai J.-S.; Chen H.-J.; Chou J.-W.; Lin S.-Y.; Chuang L.-M. |
| 臺大學術典藏 |
2022-03-10T05:59:31Z |
Inhibition of prostaglandin reductase 2, a putative oncogene overexpressed in human pancreatic adenocarcinoma, induces oxidative stress-mediated cell death involving xCT and CTH gene expressions through 15-keto-PGE2
|
Chang E.Y.-C.; YI-CHENG CHANG; Shun C.-T.; Tien Y.-W.; Tsai S.-H.; Hee S.-W.; Chen I.-J.; Chuang L.-M. |
| 臺大學術典藏 |
2022-03-09T03:12:27Z |
Rapid label-free determination of ketamine in whole blood using secondary ion mass spectrometry
|
Liao H.-Y.; Chen J.-H.; Shyue J.-J.; Shun C.-T.; HUEI-WEN CHEN; Liao S.-W.; Hong C.-K.; Chen P.-S. |
| 臺大學術典藏 |
2022-03-09T02:19:00Z |
Rapid label-free determination of ketamine in whole blood using secondary ion mass spectrometry
|
Liao H.-Y.; Chen J.-H.; Shyue J.-J.; Shun C.-T.; Chen H.-W.; Liao S.-W.; Hong C.-K.; PAI-SHAN CHEN |
| 臺大學術典藏 |
2022-03-04T08:22:58Z |
Helicobacter pylori infection and duodenal ulcer in children and adolescents.
|
Tsai C.J.; Chang M.H.; Tsai T.C.; Huang F.C.; JYH-CHIN YANG; Shun C.T. |
| 臺大學術典藏 |
2022-03-04T08:22:50Z |
Effective prevention and treatment of Helicobacter pylori infection using a combination of catechins and sialic acid in AGS cells and BALB/c mice
|
JYH-CHIN YANG; Shun C.-T.; Chien C.-T.; Wang T.-H. |
| 臺大學術典藏 |
2022-03-04T08:22:48Z |
Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication
|
JYH-CHIN YANG; Wang H.-L.; Chern H.-D.; Shun C.-T.; Lin B.-R.; Lin C.-J.; Wang T.-H. |
| 臺大學術典藏 |
2022-03-04T08:22:47Z |
Catechins and sialic acid attenuate helicobacter pylori -triggered epithelial caspase-1 activity and eradicate helicobacter pylori infection
|
JYH-CHIN YANG; Yang H.-C.; Shun C.-T.; Wang T.-H.; Chien C.-T.; Kao J.Y. |
| 臺大學術典藏 |
2022-03-04T08:22:45Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
JYH-CHIN YANG; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2022-03-04T05:33:45Z |
Laparoscopic prophylactic oophorectomy plus N3 lymphadenectomy for advanced rectosigmoid cancer
|
Liang J.-T.; Lai H.-S.; CHEN-TU WU; Huang K.-C.; Lee P.-H.; Shun C.-T. |
| 臺大學術典藏 |
2022-03-04T03:48:13Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
WEI-CHOU LIN; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:11Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
WEI-CHOU LIN; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2022-02-23T02:19:58Z |
Amplitude ultrasonic angiography-assisted diagnosis and management of cervical pregnancy
|
Sheu B.-C.; CHIH-CHENG WU; Lee C.-N.; Shun C.-T.; Lin C.-J.; Hsieh F.-J. |
| 臺大學術典藏 |
2022-02-23T02:12:39Z |
Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability
|
Lee H.-S.; Shun C.-T.; Chiou L.-L.; CHIEN-HUNG CHEN; Huang G.-T.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-22T05:34:34Z |
Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability
|
Lee H.-S.; Shun C.-T.; Chiou L.-L.; CHIEN-HUNG CHEN; Huang G.-T.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-22T03:37:27Z |
Disease progression in a patient with nonalcoholic steatohepatitis
|
PING-HUEI TSENG; Liu C.-J.; Kao J.-H.; Shun C.-T.; Chen P.-J.; Chen D.-S. |
| 臺大學術典藏 |
2022-02-22T03:37:23Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-22T03:37:23Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-22T03:37:18Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; PING-HUEI TSENG; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-22T03:37:13Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; PING-HUEI TSENG; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-22T03:37:07Z |
Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study
|
Chiang T.-H.; Chen C.-C.; PING-HUEI TSENG; Liou J.-M.; Wu M.-S.; Shun C.-T.; Lee Y.-C.; Graham D.Y. |
| 臺大學術典藏 |
2022-02-22T03:37:06Z |
Combination of Symptom Profile, Endoscopic Findings, and Esophageal Mucosal Histopathology Helps to Differentiate Achalasia from Refractory Gastroesophageal Reflux Disease
|
Yeh C.-C.; Shun C.-T.; Tseng L.-W.; Chiang T.-H.; Wu J.-F.; Lee H.-C.; Chen C.-C.; Wang H.-P.; Wu M.-S.; PING-HUEI TSENG |
| 臺大學術典藏 |
2022-02-18T08:47:02Z |
A prospective comparative study of narrow-band imaging, chromoendoscopy, and conventional colonoscopy in the diagnosis of colorectal neoplasia
|
Chiu H.-M.; Chang C.-Y.; CHIEN-CHUAN CHEN; Lee Y.-C.; Wu M.-S.; Lin J.-T.; Shun C.-T.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-18T08:47:00Z |
Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer
|
Liou J.-M.; Shun C.-T.; Liang J.-T.; Chiu H.-M.; Chen M.-J.; CHIEN-CHUAN CHEN; Wang H.-P.; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2022-02-18T08:46:59Z |
Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population
|
Liou J.-M.; Wu M.-S.; Shun C.-T.; Chiu H.-M.; Chen M.-J.; CHIEN-CHUAN CHEN; Wang H.-P.; Lin J.-T.; Liang J.-T. |
| 臺大學術典藏 |
2022-02-18T08:46:57Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEN-CHUAN CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; CHIEN-CHUAN CHEN; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-18T08:46:57Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; CHIEN-CHUAN CHEN; Chen M.-J.; CHIEN-CHUAN CHEN; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:55Z |
Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
|
Chang L.-C.; Chiu H.-M.; Shun C.-T.; Liang J.-T.; Lin J.-T.; CHIEN-CHUAN CHEN; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:53Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; Liou J.-M.; CHIEN-CHUAN CHEN; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; CHIEN-CHUAN CHEN; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:52Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; CHIEN-CHUAN CHEN; Lee Y.-C.; Chen M.-J.; CHIEN-CHUAN CHEN; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:50Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; CHIEN-CHUAN CHEN; Chang C.-Y.; Chen M.-J.; CHIEN-CHUAN CHEN; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:46:50Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; CHIEN-CHUAN CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; CHIEN-CHUAN CHEN; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:46:49Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
Tsai K.-F.; Liou J.-M.; Chen M.-J.; CHIEN-CHUAN CHEN; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:43Z |
Combination of Symptom Profile, Endoscopic Findings, and Esophageal Mucosal Histopathology Helps to Differentiate Achalasia from Refractory Gastroesophageal Reflux Disease
|
Yeh C.-C.; Shun C.-T.; Tseng L.-W.; Chiang T.-H.; Wu J.-F.; Lee H.-C.; CHIEN-CHUAN CHEN; Wang H.-P.; Wu M.-S.; Tseng P.-H. |
| 臺大學術典藏 |
2022-02-18T08:26:08Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; CHIEH-CHANG CHEN; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
